These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 26315880)
1. Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers. Lisi EC; McCandless SE J Genet Couns; 2016 Apr; 25(2):373-84. PubMed ID: 26315880 [TBL] [Abstract][Full Text] [Related]
2. Opinions of adults affected with later-onset lysosomal storage diseases regarding newborn screening: A qualitative study. Lisi EC; Ali N J Genet Couns; 2021 Dec; 30(6):1544-1558. PubMed ID: 33938615 [TBL] [Abstract][Full Text] [Related]
3. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases. Lisi EC; Gillespie S; Laney D; Ali N Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925 [TBL] [Abstract][Full Text] [Related]
4. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system. Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345 [TBL] [Abstract][Full Text] [Related]
5. Expanding newborn screening for lysosomal disorders: opportunities and challenges. Waggoner DJ; Tan CA Dev Disabil Res Rev; 2011; 17(1):9-14. PubMed ID: 22447749 [TBL] [Abstract][Full Text] [Related]
7. Newborn Screening for 6 Lysosomal Storage Disorders in China. Chang S; Zhan X; Liu Y; Song H; Gong Z; Han L; Maegawa GHB; Gu X; Zhang H JAMA Netw Open; 2024 May; 7(5):e2410754. PubMed ID: 38739391 [TBL] [Abstract][Full Text] [Related]
8. The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants. Wasserstein MP; Caggana M; Bailey SM; Desnick RJ; Edelmann L; Estrella L; Holzman I; Kelly NR; Kornreich R; Kupchik SG; Martin M; Nafday SM; Wasserman R; Yang A; Yu C; Orsini JJ Genet Med; 2019 Mar; 21(3):631-640. PubMed ID: 30093709 [TBL] [Abstract][Full Text] [Related]
9. The future of newborn screening for lysosomal disorders. Wasserstein MP; Orsini JJ; Goldenberg A; Caggana M; Levy PA; Breilyn M; Gelb MH Neurosci Lett; 2021 Aug; 760():136080. PubMed ID: 34166724 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. Burlina AB; Polo G; Salviati L; Duro G; Zizzo C; Dardis A; Bembi B; Cazzorla C; Rubert L; Zordan R; Desnick RJ; Burlina AP J Inherit Metab Dis; 2018 Mar; 41(2):209-219. PubMed ID: 29143201 [TBL] [Abstract][Full Text] [Related]
11. Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications. La Cognata V; Guarnaccia M; Morello G; Ruggieri M; Polizzi A; Cavallaro S Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576242 [TBL] [Abstract][Full Text] [Related]
12. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America. Giugliani R J Inherit Metab Dis; 2012 Sep; 35(5):871-7. PubMed ID: 22231381 [TBL] [Abstract][Full Text] [Related]
13. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry. Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910 [TBL] [Abstract][Full Text] [Related]
14. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri. Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528 [TBL] [Abstract][Full Text] [Related]
15. Newborn screening for Pompe disease: impact on families. Pruniski B; Lisi E; Ali N J Inherit Metab Dis; 2018 Nov; 41(6):1189-1203. PubMed ID: 29594646 [TBL] [Abstract][Full Text] [Related]
16. A qualitative assessment of parental experiences with false-positive newborn screening for Krabbe disease. Peterson L; Siemon A; Olewiler L; McBride KL; Allain DC J Genet Couns; 2022 Feb; 31(1):252-260. PubMed ID: 34265137 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for lysosomal storage disorders. Nakamura K; Hattori K; Endo F Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327 [TBL] [Abstract][Full Text] [Related]
18. A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease. Jalal K; Carter RL; Barczykowski A; Tomatsu S; Langan TJ Int J Neonatal Screen; 2022 Nov; 8(4):. PubMed ID: 36412587 [TBL] [Abstract][Full Text] [Related]
19. Newborn screening of lysosomal storage disorders. Marsden D; Levy H Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136 [TBL] [Abstract][Full Text] [Related]
20. Health care practitioners' experience-based opinions on providing care after a positive newborn screen for Pompe disease. Davids L; Sun Y; Moore RH; Lisi E; Wittenauer A; Wilcox WR; Ali N Mol Genet Metab; 2021; 134(1-2):20-28. PubMed ID: 34602357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]